{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:14:45Z","timestamp":1787030085015,"version":"build-2736575974"},"reference-count":12,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Functional urology involves a large scale of lower urinary tract dysfunctions (LUTDs), including bladder dysfunctions and bladder outlet dysfunctions [...]<\/jats:p>","DOI":"10.3390\/toxins15050321","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T02:29:22Z","timestamp":1683512962000},"page":"321","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Botulinum Toxin Brings a Light to the Shadow of Functional Urology"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-4771","authenticated-orcid":false,"given":"Hann-Chorng","family":"Kuo","sequence":"first","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,6]]},"reference":[{"key":"ref_1","unstructured":"FDA (2011). FDA Approves Botox to Treat Specific Form of Incontinence."},{"key":"ref_2","unstructured":"FDA (2023, April 22). Approves Botox to Treat Overactive Bladder, Available online: https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm336101.htm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11255-022-03107-6","article-title":"An indirect comparison meta-analysis of noninvasive intravesical instillation and intravesical injection of botulinum toxin-A in bladder disorders","volume":"54","author":"Gao","year":"2022","journal-title":"Int. Urol. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.apmr.2011.11.020","article-title":"Spinal Cord Injury Rehabilitation Evidence Research Team. A meta-analysis of botulinum toxin sphincteric injections in the treatment of incomplete voiding after spinal cord injury","volume":"93","author":"Mehta","year":"2012","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","article-title":"Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: Clinical and urodynamic results","volume":"55","author":"Giannantoni","year":"2009","journal-title":"Eur. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Chen, G., Liao, L., and Zhang, F. (2019). Efficacy and safety of botulinum toxin a injection into urethral sphincter for underactive bladder. BMC Urol., 19.","DOI":"10.1186\/s12894-019-0490-4"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000087803","article-title":"Effectiveness of urethral injection of botulinum A toxin in the treatment of voiding dysfunction after radical hysterectomy","volume":"75","author":"Kuo","year":"2005","journal-title":"Urol. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/bju.12951","article-title":"Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis\/chronic pelvic pain syndrome: Results of a prospective pilot double-blind and randomized placebo-controlled study","volume":"116","author":"Falahatkar","year":"2015","journal-title":"BJU Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.urology.2006.05.056","article-title":"Intravesical injection of botulinum toxin type A: Management of neuropathic bladder and bowel dysfunction in children with myelomeningocele","volume":"68","author":"Kajbafzadeh","year":"2006","journal-title":"Urology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/nau.21124","article-title":"Repeated botulinum-A toxin injection in the treatment of neuropathic bladder dysfunction and poor bladder compliance in children with myelomeningocele","volume":"30","author":"Horst","year":"2011","journal-title":"Neurourol. Urodyn."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Janicki, J.J., Chancellor, M.B., Kaufman, J., Gruber, M.A., and Chancellor, D.D. (2016). Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction. Toxins, 8.","DOI":"10.3390\/toxins8030081"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.juro.2015.12.078","article-title":"Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using low energy shock waves","volume":"196","author":"Chuang","year":"2016","journal-title":"J. Urol."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/15\/5\/321\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:30:11Z","timestamp":1760124611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/15\/5\/321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,6]]},"references-count":12,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["toxins15050321"],"URL":"https:\/\/doi.org\/10.3390\/toxins15050321","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,6]]}}}